About Auro Peptides Limited
Data last updated: 22 December 2025
Auro Peptides Limited is a public limited company based in Hyderabad, Telangana, India, a subsidiary of Aurobindo Pharma Ltd. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 02 January 2012, the company has been in operation for over 14 years.
Registered with ROC Hyderabad under CIN U24232TG2012PLC078350.
Capital: an authorised share capital of ₹450.1 Cr and a paid-up capital of ₹336.1 Cr. It is led by directors including Sivakumaran Meenakshisunderam and Mudiraj Saritha Rani.
Last AGM: 01 September 2025. Financial statements filed for year ended 31 March 2025. Office: Galaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.52 Cr, a decline of 14% compared to the previous year.
The company has a workforce of approximately 169 employees as per the latest available data. It operates as a subsidiary of Aurobindo Pharma Ltd.
The company is associated with 1 brand - Aurobindo Pharma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aurobindo.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressGalaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Auro Peptides Limited
Auro Peptides Limited has one previous CIN (Corporate Identification Number): U24232AP2012PLC078350. The current CIN is U24232TG2012PLC078350, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2012PLC078350 | Current |
| U24232AP2012PLC078350 | Previous |
Associated Brands with Auro Peptides Limited
Auro Peptides Limited operates one associated brand: Aurobindo Pharma. These brands represent Auro Peptides Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Generic biocatalytic solutions are provided for pharmaceutical applications. | aurobindo.com |
Competitors & Alternatives of Auro Peptides Limited
Brands and companies operating in the same space as Auro Peptides Limited include Concord Biotech, BDR Pharmaceuticals Internationals, Almac Group and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Concord Biotech
|
APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India, India | 2000 |
BDR Pharmaceuticals Internationals
|
APIs and finished products are developed and manufactured. | Mumbai, India, India | 2003 |
Almac Group
|
Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom, United Kingdom | 2001 |
Indoco Remedies
|
APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India, India | 1947 |
Pharmaceutics International
|
Pharmaceutical dosage forms are manufactured by this CDMO. | Hunt Valley, United States, United States | 1994 |
Seqens
|
Contract manufacturing services for small molecules and peptides are provided. | Ecully, France, France | 2003 |
Asymchem
|
APIs and peptides are developed and manufactured by Asymchem. | Morrisville, United States, United States | 1995 |
Biophore
|
Niche generic pharmaceuticals are developed and manufactured for industry needs. | Hyderabad, India, India | 2007 |
Continuus Pharma
|
MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | Woburn, United States, United States | 2012 |
Business Activity of Auro Peptides Limited
Auro Peptides Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Auro Peptides Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Auro Peptides Limited
Auro Peptides Limited is audited by Reddy AV &Co for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Reddy AV &Co | Locked | Locked | Locked |
Complete auditor history for Auro Peptides Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Auro Peptides Limited
Auro Peptides Limited is currently managed by 7 directors, with 16 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Sivakumaran Meenakshisunderam
Also directs:
Curateq Biologics Private Limited, Tergene Biotech Limited, Auro Peptides Limited and 3 more
|
Director | 29 Sep 2017 | 8 Years 10 Months | Current |
|
Mudiraj Saritha Rani
Also directs:
Auro Peptides Limited
|
Director | 15 Jun 2022 | 4 Years 2 Months | Current |
|
Chandra Reddy Tirumalareddy
Also directs:
Auro Peptides Limited
|
Whole-Time Director | 23 May 2019 | 7 Years 2 Months | Current |
|
Mylandlahalli Rammohan Ashwini
Also directs:
Curateq Biologics Private Limited, Auro Peptides Limited, Apl Healthcare Limited and 4 more
|
Additional Director | 30 Oct 2025 | 0 Years 9 Months | Current |
|
Satakarni Makkapati
Also directs:
Auro Peptides Limited, Aurobindo Pharma Ltd, Engenra Biologics Private Limited and 3 more
|
Director | 02 Nov 2021 | 4 Years 9 Months | Current |
| Naga Venkata Subbarao Kesavarapu | Director | 20 Jan 2023 | 3 Years 7 Months | Current |
Financials of Auro Peptides Limited FY 2025 filings available
Auro Peptides Limited reported revenue of ₹23.52 Cr (down 14.00% YoY) for FY 2025.
Ten-year financial statements for Auro Peptides Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Auro Peptides Limited
Shareholding and ownership data for Auro Peptides Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings Auro Peptides Limited
Auro Peptides Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Auro Peptides Limited
Auro Peptides Limited has a workforce of 169 employees as of Apr 06, 2024.
Employee and EPFO history for Auro Peptides Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Auro Peptides Limited
GST registrations and filing compliance for Auro Peptides Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Auro Peptides Limited
Credit ratings, litigation, and regulatory alerts for Auro Peptides Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Auro Peptides Limited
MSME payment history for Auro Peptides Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Auro Peptides Limited
Corporate group structure for Auro Peptides Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Auro Peptides Limited
MCA filings and documents for Auro Peptides Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Auro Peptides Limited
Recent News on Auro Peptides Limited
Frequently Asked Questions about Auro Peptides Limited
Auro Peptides Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 02 January 2012 (14+ years old) and is registered under CIN U24232TG2012PLC078350. The company has 169 employees.
Auro Peptides Limited reported revenue of ₹23.52 Cr for FY 2025 (down 14.00% YoY).
The current directors of Auro Peptides Limited are:
- Sivakumaran Meenakshisunderam - Director
- Mudiraj Saritha Rani - Director
- Chandra Reddy Tirumalareddy - Whole-Time Director
- Mylandlahalli Rammohan Ashwini - Additional Director
- Satakarni Makkapati - Director
- Naga Venkata Subbarao Kesavarapu - Director
- Rajendra Rekapu Krishna - Additional Director
The primary industry of Auro Peptides Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Auro Peptides Limited can be reached at the registered office: Galaxy Floors 22 – 24 Plot No. 1 Survey No. 831 Hyderabad Knowledge City Raidurg Panmak, Tha, Telangana, India – 500032, or through the website aurobindo.com.
The authorised capital is ₹450.1 Cr, and the paid-up capital is ₹336.1 Cr.